Home>
Stocks>
Kopran Share Price

Kopran Stock Performance

as on February 10, 2026 at 9:31 pm IST

Day's Low
Day's High
₹142.00
Day's Price Range
₹146.83
₹142.88
0.62%
Downside
2.76%
Upside
52 Week's Low
52 Week's High
₹119.81
52-Week Price Range
₹214.00
₹142.88
16.15%
Downside
49.78%
Upside

Kopran share price movements today

Previous Close: ₹142.14
Open: ₹142.50
Volume: 1.47L
Upper Circuit: ₹170.56
Lower Circuit: ₹113.72
Day's Low - High: ₹142.00 - ₹146.83
52 Week Low - High: ₹119.81 - ₹214.00

Kopran Historical Returns

1 Month Return: -3.62 %
3 Month Return: -10.2 %
1 Year Return: -15.99 %
3 Year Return: + 11.49 %
5 Year Return: + 12.46 %

Kopran Fundamentals

as on February 10, 2026 at 4:01 pm IST

Market Cap

₹686.33 Cr

Return on Equity (ROE)

6.33

PE Ratio (TTM)

41.56

Return on capital employed (ROCE)

8.54

Industry PE ratio

40.65

Beta (LTM)

1.38

P/B Ratio

1.96

Dividend Yield

1.71

PEG Ratio

-6.46

Quarterly Earnings Growth YOY

-10.19

EPS (TTM)

7.98

Sector

Pharmaceuticals

Book Value

107.35

Technical Analysis

Bullish

View Technical Analysis

Kopran Stock Valuation

as on February 10, 2026 at 4:01 pm IST

Kopran in the last 5 years

Overview
Trends

Lowest (3.00x)

March 24, 2020

Industry (40.65x)

February 9, 2026

Today (41.56x)

February 9, 2026

Highest (53.33x)

September 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 41.56x

Kopran Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kopran with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Kopran Ltd	NA	686.33	2.49%	0.62	38	629
Kwality Pharmaceuticals Ltd	NA	1,210.49	386.14%	0.65	39	370
Vivo Bio Tech Ltd	NA	63.02	-9.02%	0.71	7	46
Novartis India Ltd	NA	2,071.56	6.32%	0.00	100	390
Beryl Drugs Ltd	NA	11.16	34.2%	0.00	-1	21

See all

Kopran Share Price Target

Get share price movements and forecasts by analysts on Kopran.

Source: S&P Global Market Intelligence

Kopran Ltd Quarterly Profit & Loss

Figures in Rupees Crores

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	148.88	117	152.59	158.92	186.08	139.44	151.56	166.24	172.36	135.22	117.91	194.28
Other Income	3.78	2.39	0.13	2.43	9.67	2.63	1	0.17	3.26	2.56	0.03	0.07
Total Income	152.66	119.39	152.72	161.35	195.75	142.06	152.56	166.41	175.62	137.77	117.93	194.35
Expenses	136.72	110.69	129.76	135.34	164.39	121.27	136.82	146.4	155.28	121.09	123.19	176.52
Operating Profit	12.16	6.31	22.83	23.58	21.69	18.17	14.74	19.84	17.08	14.13	-5.28	17.76
Operating Profit Margin %	8.17%	5.39%	14.96%	14.84%	11.66%	13.03%	9.73%	11.93%	9.91%	10.45%	-4.48%	9.14%
Profit Before Interest, Tax and Depreciation	15.94	8.7	22.96	26.01	31.36	20.79	15.73	20.01	20.35	16.69	-5.25	17.83
Interest	1.78	1.83	1.94	2.24	2.59	2.18	2.23	2.16	2.77	2.54	2.09	2.67
Depreciation	3.24	3.26	2.77	3.27	3.59	3.87	3.85	4	3.87	4.26	4.28	4.42
Profit Before Tax	10.92	3.61	18.25	20.5	25.18	14.74	9.65	13.85	13.71	9.89	-11.62	10.74
Tax Paid	2.88	0.83	4.48	4.72	6.55	3.64	2.26	3.46	4.03	2.44	-1.7	1.4
Profit After Tax	8.04	2.77	13.77	15.79	18.62	11.1	7.38	10.4	9.68	7.45	-9.92	9.34
Total Net profit including share of profit / Loss from associate company	8.04	2.77	13.77	15.79	18.62	11.1	7.38	10.4	9.68	7.45	-9.92	9.34
EPS	1.67	0.58	2.86	3.28	3.86	2.3	1.53	2.16	2.01	1.54	-2.06	1.93
Actual EPS	1.67	0.58	2.86	3.28	3.86	2.3	1.53	2.16	2.01	1.54	-2.06	1.93
Adjusted EPS	1.67	0.58	2.86	3.28	3.86	2.3	1.53	2.16	2.01	1.54	-2.06	1.93
Diluted EPS	1.67	0.58	2.85	3.28	3.85	2.3	1.53	2.15	2.01	1.54	-2.06	1.93

Kopran Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	318.71	314.71	357.9	359.5	491.81	477.52	550.99	614.59	629.6
Other Income	10.77	9.6	3.06	0.63	17.99	10.6	3.07	14.61	3.98
Total Income	329.48	324.3	360.96	360.13	509.8	488.13	554.05	629.2	633.59
Expenses	282.69	284.31	311.57	313.36	410.03	390.13	499.19	540.18	556.7
Operating Profit	36.02	30.4	46.33	46.14	81.78	87.39	51.8	74.41	72.9
Operating Profit Margin %	11.3%	9.66%	12.94%	12.83%	16.63%	18.3%	9.4%	12.11%	11.58%
Profit Before Interest, Tax and Depreciation	46.79	39.99	49.39	46.77	99.77	98	54.86	89.02	76.88
Interest	13.7	8.6	8.99	8.91	6.24	5.12	6.08	8.59	9.34
Depreciation	8.33	8.51	8.74	9.58	10.19	11.1	12.71	12.89	15.59
Profit Before Tax	24.76	22.88	31.66	28.28	83.34	81.78	36.07	67.54	51.95
Tax Paid	4.85	2.4	7.64	7.27	21.73	20.75	8.83	16.59	13.39
Profit After Tax	19.91	20.49	24.02	21.02	61.61	61.03	27.23	50.96	38.55
Total Net profit including share of profit / Loss from associate company	19.91	20.49	24.02	21.02	61.61	61.03	27.23	50.96	38.55
EPS	4.6	4.74	5.55	4.86	14.24	13.77	5.65	10.57	7.99
Actual EPS	4.6	4.74	5.55	4.86	14.24	13.77	5.65	10.57	7.99
Adjusted EPS	4.6	4.74	5.55	4.86	14.24	13.77	5.65	10.57	7.99
Diluted EPS	4.6	4.74	5.55	4.86	14.24	13.77	5.65	10.55	7.99

Kopran Ltd Cash Flow

Figures in Rupees Crores

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Cash from Operating Activities	28.63	15.87	25.77	25.41	31	59.95	-33.48	34.02	43.26	41.94
Cash Flow from Investing Activities	-9.07	-17.97	-10.98	-24.86	-12.51	-28.96	-84.13	-12.58	-43.55	-56.42
Cash Flow from Financing Activities	-19.34	1.97	-15.02	-0.59	-18.06	-34.58	122.82	-19.84	0.99	25.88
Net Cash Flow	0.22	-0.12	-0.22	-0.03	0.42	0.1	4.93	1.53	0.69	11.38

Kopran Stock Shareholding Pattern

Numbers in percentages

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	44.3%	44.49%	44.49%	44.49%	44.49%	44.49%	44.49%	44.46%	44.42%	44.42%	44.42%	44.42%
DII	0.14%	0.14%	0.35%	0.14%	1.2%	0.14%	0.22%	0%	0%	0%	0%	0%
FII	0%	0%	0%	0.48%	0.84%	0.68%	1.32%	0.86%	1.12%	0.76%	0.6%	0.36%
Public	55.15%	55.03%	54.77%	54.89%	53.47%	54.7%	53.97%	54.68%	54.45%	54.82%	54.98%	55.22%
Total Outstanding Shares	4,82,10,605	4,82,10,605	4,82,10,605	4,82,10,605	4,82,10,605	4,82,10,605	4,82,10,605	4,82,49,405	4,82,85,605	4,82,85,605	4,82,85,605	4,82,85,605
Total Shareholders	41,567	44,038	53,791	51,636	50,850	51,492	57,154	60,560	58,652	60,194	62,222	60,886

Mutual Funds that own Kopran Stock

Check out the Mutual Funds with significant holdings in Kopran.

Funds	Holdings	Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth	0.03%	333

Indices Featuring Kopran Stock

Check stock indices that include Kopran.

BSE Healthcare

₹42,603.55

0.07 (▲28.76%)

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 117.93 Cr → 194.35 Cr (in ₹), with an average increase of 39.3% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, KOPRAN stock has moved up by 6.2%
POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 54.98% to 55.22% in Dec 2025 quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -9.92 Cr → 9.34 Cr (in ₹), with an average increase of 206.2% per quarter
NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 162.8% return, outperforming this stock by 145.5%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.42% of holdings in Dec 2025 quarter
NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.2% return, outperforming this stock by 45.5%
NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.60% to 0.36% in Dec 2025 quarter

About Kopran Ltd

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Revenue: ₹194.28Cr as on December 2025 (Q3 FY26)
Net Profit: ₹9.34Cr as on December 2025 (Q3 FY26)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani

Organisation	Kopran Ltd
Industry	Pharmaceuticals
CEO	Susheel Somani
E-voting on shares	Click here to vote

FAQs

What is Kopran share price today?

Kopran share price today stands at ₹142.88 as on February 10, 2026 at 4:01 pm IST at the close of the market. Kopran share today touched a day high of ₹146.83 and a low of ₹142.

What is the 52 week high and 52 week low range for Kopran share?

Kopran touched a 52 week high of ₹214 and a 52 week low of ₹119.81. Kopran share price today i.e. February 10, 2026 at 4:01 pm IST is closed at ₹142.88, which is -33.23% down from its 52 week high and 19.26% up from its 52 week low.

What is Kopran's market capitalisation today?

Kopran market capitalisation is ₹686.33 Cr as on February 10, 2026 at 4:01 pm IST.

How to buy Kopran shares?

To buy Kopran shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for KOPRAN or Kopran Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Kopran shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kopran trading volume today?

Kopran trading volume is 1.47L as on February 10, 2026 at 4:01 pm IST. This means that 1.47L shares of Kopran were bought and sold on the stock market during today's trading session.